SPECIAL NOTICE
99 -- Sources Sought Notice � IMPROVE Project
- Notice Date
- 3/29/2022 2:44:52 PM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- NIH National Cancer Institute Rockville MD 20850 USA
- ZIP Code
- 20850
- Solicitation Number
- S22-049
- Response Due
- 4/25/2022 9:00:00 AM
- Point of Contact
- Natalie Fielman
- E-Mail Address
-
Natalie.Fielman@nih.gov
(Natalie.Fielman@nih.gov)
- Description
- National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: The goal of this solicitation is to award multiple subcontracts to fund extramural research entities with significant experience in AI especially deep learning research and development to create the Collaborative Core Modeling Group (CCMG). The CCMG will work collaboratively with the IMPROVE teams at Argonne National Laboratory (ANL) and Frederick National Laboratory for Cancer Research (FNLCR) to develop semi-automatic protocols for comparing cancer therapeutic response deep learning models and identifying model attributes that contribute to prediction performance with the goal of IMPROVING future models for multiple use cases. This RFP focuses on IMPROVE Model Comparison: development of semi-automatic protocols for comparing cancer therapeutic response deep learning models and identifying model attributes that contribute to prediction performance with the goal of IMPROVING future models. NOTE: A separate RFI has been issued for IMPROVE Data Generation.� A PRE-OFFER SUBMISSION VIRTUAL CONFERENCE WILL BE HELD ON APRIL 6, 2022 AT 3 P.M.� 5 P.M. ET. The agenda includes an overview of the IMPROVE project, the RFP tasks, how to work with FNL, and the bidding process. Questions may be submitted in advance to Natalie Fielman and Josh Wynne (natalie.fielman@nih.gov/ josh.wynne@nih.gov). Answers will be provided at the Conference. Offerors also can submit questions during the conference and replies will be sent to all attendees afterward. Potential offerors are encouraged to participate in this conference by registering at: https://events.cancer.gov/nci/improvebiddersconference For information concerning opportunities with the FNLCR, please contact the Leidos Biomedical Research Point of Contact listed in this announcement. Background Information:� Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick.� The effort to be performed will be part of Leidos Biomed�s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. Leidos Biomedical Research, Inc. POC:� Subcontracts Administrator at Natalie.Fielman@nih.gov
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/82aafd08a7da427a8cf092d53eb6ae93/view)
- Record
- SN06282183-F 20220331/220329230100 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |